Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,937 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Sphingosine-1-phosphate promotes tumor development and liver fibrosis in mouse model of congestive hepatopathy.
Kawai H, Osawa Y, Matsuda M, Tsunoda T, Yanagida K, Hishikawa D, Okawara M, Sakamoto Y, Shimagaki T, Tsutsui Y, Yoshida Y, Yoshikawa S, Hashi K, Doi H, Mori T, Yamazoe T, Yoshio S, Sugiyama M, Okuzaki D, Komatsu H, Inui A, Tamura-Nakano M, Oyama C, Shindou H, Kusano H, Kage M, Ikegami T, Yanaga K, Kanto T. Kawai H, et al. Among authors: matsuda m. Hepatology. 2022 Jul;76(1):112-125. doi: 10.1002/hep.32256. Epub 2021 Dec 22. Hepatology. 2022. PMID: 34855990
Serum soluble sialic acid-binding immunoglobulin-like lectin-7 concentration as an indicator of liver macrophage activation and advanced fibrosis in patients with non-alcoholic fatty liver disease.
Sakamoto Y, Yoshio S, Doi H, Kawai H, Shimagaki T, Mori T, Matsuda M, Aoki Y, Osawa Y, Yoshida Y, Arai T, Itokawa N, Ito T, Seko Y, Yamaguchi K, Itoh Y, Mise Y, Saiura A, Taketomi A, Kanto T. Sakamoto Y, et al. Among authors: matsuda m. Hepatol Res. 2020 Apr;50(4):466-477. doi: 10.1111/hepr.13464. Epub 2019 Dec 26. Hepatol Res. 2020. PMID: 31808236
Peripheral-dominant liver fibrosis and tumor distribution in a mouse model of congestive hepatopathy.
Kawai H, Osawa Y, Tsunoda T, Matsuda M, Okawara M, Sakamoto Y, Shimagaki T, Tsutsui Y, Yoshida Y, Yoshikawa S, Doi H, Mori T, Yamazoe T, Yoshio S, Okamura T, Sugiyama M, Okuzaki D, Komatsu H, Inui A, Yanaga K, Ikegami T, Kanto T. Kawai H, et al. Among authors: matsuda m. Hepatol Res. 2023 Apr;53(4):370-376. doi: 10.1111/hepr.13866. Epub 2022 Dec 13. Hepatol Res. 2023. PMID: 36461886
Exercise changes the intrahepatic immune cell profile and inhibits the progression of nonalcoholic steatohepatitis in a mouse model.
Tsutsui Y, Mori T, Yoshio S, Sato M, Sakata T, Yoshida Y, Kawai H, Yoshikawa S, Yamazoe T, Matsuda M, Kakazu E, Osawa Y, Oyama C, Tamura-Nakano M, Kawaguchi T, Yoshizumi T, Kanto T. Tsutsui Y, et al. Among authors: matsuda m. Hepatol Commun. 2023 Sep 27;7(10):e0236. doi: 10.1097/HC9.0000000000000236. eCollection 2023 Oct 1. Hepatol Commun. 2023. PMID: 37756046 Free PMC article.
Repurposing of the analgesic Neurotropin for MASLD/MASH treatment.
Tsuchiya T, Kim SY, Matsuda M, Kim J, Stotland A, Naiki M, Seki E. Tsuchiya T, et al. Among authors: matsuda m. Hepatol Commun. 2024 Jul 18;8(8):e0480. doi: 10.1097/HC9.0000000000000480. eCollection 2024 Aug 1. Hepatol Commun. 2024. PMID: 39023282 Free PMC article.
Increased Frequency of Dysfunctional Siglec-7-CD57+PD-1+ Natural Killer Cells in Patients With Non-alcoholic Fatty Liver Disease.
Sakamoto Y, Yoshio S, Doi H, Mori T, Matsuda M, Kawai H, Shimagaki T, Yoshikawa S, Aoki Y, Osawa Y, Yoshida Y, Arai T, Itokawa N, Atsukawa M, Ito T, Honda T, Mise Y, Ono Y, Takahashi Y, Saiura A, Taketomi A, Kanto T. Sakamoto Y, et al. Among authors: matsuda m. Front Immunol. 2021 Feb 22;12:603133. doi: 10.3389/fimmu.2021.603133. eCollection 2021. Front Immunol. 2021. PMID: 33692781 Free PMC article. Clinical Trial.
3,937 results